_id
6919ebe83c536f8df23183b0
Ticker
NCYT.LSE
Name
Novacyt
Exchange
LSE
Address
131 Boulevard Carnot, Le Vésinet, France, 78110
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://www.novacyt.com
Description
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.
Last Close
354500
Volume
45298
Current Price
34.696
Change
-1.5514809590973322
Last Updated
2025-12-30T11:18:14.536Z
Image
https://logo.clearbit.com/www.novacyt.com
Ipo Date
-
Market Cap
25037004
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
9976810
Cost Of Revenue
1643000
Gross Profit
3253500
Operating Expenses
6825000
Operating Income
-6674978
Interest Expense
328043
Pretax Income
-7157874
Net Income
-3171000
Eps
-0.044898321655144416
Dividends Per Share
-
Shares Outstanding
70626248
Income Tax Expense
-272011
EBITDA
-4500926
Operating Margin
-66.90493253855692
Total Other Income Expense Net
-482896
Cash
27626060
Short Term Investments
11653
Receivables
5350271
Inventories
2981166
Total Current Assets
33747480
Property Plant Equipment
11618164
Total Assets
63030223
Payables
1580739
Short Term Debt
2071697
Long Term Debt
-
Total Liabilities
22120331
Equity
47590192
Bs_currency_symbol
-
Depreciation
1012000
Change In Working Capital
-552000
Cash From Operations
-5243606
Capital Expenditures
90500
Cash From Investing
-507347
Cash From Financing
-1130834
Net Change In Cash
-6728248
Cf_currency_symbol
-
PE
-
PB
51.490615978351165
ROE
-6.6631376481944
ROA
-5.030919849355444
FCF
-5334106
Fcf Percent
-0.5346504544037624
Piotroski FScore
0
Health Score
26
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
4
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
9976810
Quarters > 0 > income Statement > cost Of Revenue
1643000
Quarters > 0 > income Statement > gross Profit
3253500
Quarters > 0 > income Statement > operating Expenses
6825000
Quarters > 0 > income Statement > operating Income
-6674978
Quarters > 0 > income Statement > interest Expense
328043
Quarters > 0 > income Statement > pretax Income
-7157874
Quarters > 0 > income Statement > net Income
-3171000
Quarters > 0 > income Statement > eps
-0.044898321655144416
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
70626248
Quarters > 0 > income Statement > income Tax Expense
-272011
Quarters > 0 > income Statement > EBITDA
-4500926
Quarters > 0 > income Statement > operating Margin
-66.90493253855692
Quarters > 0 > income Statement > total Other Income Expense Net
-482896
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
27626060
Quarters > 0 > balance Sheet > short Term Investments
11653
Quarters > 0 > balance Sheet > receivables
5350271
Quarters > 0 > balance Sheet > inventories
2981166
Quarters > 0 > balance Sheet > total Current Assets
33747480
Quarters > 0 > balance Sheet > property Plant Equipment
11618164
Quarters > 0 > balance Sheet > total Assets
63030223
Quarters > 0 > balance Sheet > payables
1580739
Quarters > 0 > balance Sheet > short Term Debt
2071697
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
22120331
Quarters > 0 > balance Sheet > equity
47590192
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-3171000
Quarters > 0 > cash Flow > depreciation
1012000
Quarters > 0 > cash Flow > change In Working Capital
-552000
Quarters > 0 > cash Flow > cash From Operations
-5243606
Quarters > 0 > cash Flow > capital Expenditures
90500
Quarters > 0 > cash Flow > cash From Investing
-507347
Quarters > 0 > cash Flow > cash From Financing
-1130834
Quarters > 0 > cash Flow > net Change In Cash
-6728248
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.044898321655144416
Quarters > 0 > ratios > PB
51.490615978351165
Quarters > 0 > ratios > ROE
-6.6631376481944
Quarters > 0 > ratios > ROA
-5.030919849355444
Quarters > 0 > ratios > FCF
-5334106
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.5346504544037624
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
4896500
Quarters > 1 > income Statement > cost Of Revenue
1643000
Quarters > 1 > income Statement > gross Profit
3253500
Quarters > 1 > income Statement > operating Expenses
6825000
Quarters > 1 > income Statement > operating Income
-3571500
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3513000
Quarters > 1 > income Statement > net Income
-3171000
Quarters > 1 > income Statement > eps
-0.044898321655144416
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
70626248
Quarters > 1 > income Statement > income Tax Expense
133500
Quarters > 1 > income Statement > EBITDA
-2166500
Quarters > 1 > income Statement > operating Margin
-72.93985499846829
Quarters > 1 > income Statement > total Other Income Expense Net
58500
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
28308008
Quarters > 1 > balance Sheet > short Term Investments
11940
Quarters > 1 > balance Sheet > receivables
4735713
Quarters > 1 > balance Sheet > inventories
3553576
Quarters > 1 > balance Sheet > total Current Assets
40227295
Quarters > 1 > balance Sheet > property Plant Equipment
11904958
Quarters > 1 > balance Sheet > total Assets
75132585
Quarters > 1 > balance Sheet > payables
1884255
Quarters > 1 > balance Sheet > short Term Debt
1141538
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
26367632
Quarters > 1 > balance Sheet > equity
48764953
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-3171000
Quarters > 1 > cash Flow > depreciation
1012000
Quarters > 1 > cash Flow > change In Working Capital
-552000
Quarters > 1 > cash Flow > cash From Operations
-2737000
Quarters > 1 > cash Flow > capital Expenditures
90500
Quarters > 1 > cash Flow > cash From Investing
-85500
Quarters > 1 > cash Flow > cash From Financing
-555000
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.044898321655144416
Quarters > 1 > ratios > PB
50.250193014807174
Quarters > 1 > ratios > ROE
-6.502620847394234
Quarters > 1 > ratios > ROA
-4.220538931277288
Quarters > 1 > ratios > FCF
-2827500
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.5774532829572143
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
9183900
Quarters > 2 > income Statement > cost Of Revenue
7577606
Quarters > 2 > income Statement > gross Profit
1606294
Quarters > 2 > income Statement > operating Expenses
8916513
Quarters > 2 > income Statement > operating Income
-7310219
Quarters > 2 > income Statement > interest Expense
331520
Quarters > 2 > income Statement > pretax Income
-21225190
Quarters > 2 > income Statement > net Income
-23738232
Quarters > 2 > income Statement > eps
-0.33611061994968217
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
70626248
Quarters > 2 > income Statement > income Tax Expense
-506160
Quarters > 2 > income Statement > EBITDA
-16980547
Quarters > 2 > income Statement > operating Margin
-79.5981990222019
Quarters > 2 > income Statement > total Other Income Expense Net
-13914971
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
30453000
Quarters > 2 > balance Sheet > short Term Investments
8000
Quarters > 2 > balance Sheet > receivables
3713000
Quarters > 2 > balance Sheet > inventories
2269000
Quarters > 2 > balance Sheet > total Current Assets
39376000
Quarters > 2 > balance Sheet > property Plant Equipment
10701000
Quarters > 2 > balance Sheet > total Assets
70632000
Quarters > 2 > balance Sheet > payables
462000
Quarters > 2 > balance Sheet > short Term Debt
1257000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
22752000
Quarters > 2 > balance Sheet > equity
47880000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-20719029
Quarters > 2 > cash Flow > depreciation
3913123
Quarters > 2 > cash Flow > change In Working Capital
6997036
Quarters > 2 > cash Flow > cash From Operations
-438777
Quarters > 2 > cash Flow > capital Expenditures
549352
Quarters > 2 > cash Flow > cash From Investing
-1192924
Quarters > 2 > cash Flow > cash From Financing
-978843
Quarters > 2 > cash Flow > net Change In Cash
-2438030
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.33611061994968217
Quarters > 2 > ratios > PB
51.17895364678362
Quarters > 2 > ratios > ROE
-49.57859649122807
Quarters > 2 > ratios > ROA
-33.60832483860007
Quarters > 2 > ratios > FCF
-988129
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.10759361491305437
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
10232919
Quarters > 3 > income Statement > cost Of Revenue
6926701
Quarters > 3 > income Statement > gross Profit
3306218
Quarters > 3 > income Statement > operating Expenses
12244410
Quarters > 3 > income Statement > operating Income
-8938190
Quarters > 3 > income Statement > interest Expense
393573
Quarters > 3 > income Statement > pretax Income
-17763365
Quarters > 3 > income Statement > net Income
-17546255
Quarters > 3 > income Statement > eps
-0.2484381585724333
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70626248
Quarters > 3 > income Statement > income Tax Expense
-217110
Quarters > 3 > income Statement > EBITDA
-14007064
Quarters > 3 > income Statement > operating Margin
-87.34741279589919
Quarters > 3 > income Statement > total Other Income Expense Net
-8825175
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
32914430
Quarters > 3 > balance Sheet > short Term Investments
7994.03
Quarters > 3 > balance Sheet > receivables
17365037
Quarters > 3 > balance Sheet > inventories
2998761
Quarters > 3 > balance Sheet > total Current Assets
54947982
Quarters > 3 > balance Sheet > property Plant Equipment
13777715
Quarters > 3 > balance Sheet > total Assets
99324856
Quarters > 3 > balance Sheet > payables
2382221
Quarters > 3 > balance Sheet > short Term Debt
1350991
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
28964378
Quarters > 3 > balance Sheet > equity
70360477
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-8849500
Quarters > 3 > cash Flow > depreciation
-8178000
Quarters > 3 > cash Flow > change In Working Capital
10029500
Quarters > 3 > cash Flow > cash From Operations
-4543500
Quarters > 3 > cash Flow > capital Expenditures
369000
Quarters > 3 > cash Flow > cash From Investing
-566500
Quarters > 3 > cash Flow > cash From Financing
-430500
Quarters > 3 > cash Flow > net Change In Cash
-5557500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.2484381585724333
Quarters > 3 > ratios > PB
34.82705639713045
Quarters > 3 > ratios > ROE
-24.937657827419223
Quarters > 3 > ratios > ROA
-17.665522716690372
Quarters > 3 > ratios > FCF
-4912500
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.4800682972277998
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
19630000
Annuals > 0 > income Statement > cost Of Revenue
-12444000
Annuals > 0 > income Statement > gross Profit
32074000
Annuals > 0 > income Statement > operating Expenses
69417000
Annuals > 0 > income Statement > operating Income
-37343000
Annuals > 0 > income Statement > interest Expense
5121000
Annuals > 0 > income Statement > pretax Income
-39430000
Annuals > 0 > income Statement > net Income
-41758000
Annuals > 0 > income Statement > eps
-0.5912532688979881
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
70626248
Annuals > 0 > income Statement > income Tax Expense
-732000
Annuals > 0 > income Statement > EBITDA
-34309000
Annuals > 0 > income Statement > operating Margin
-190.23433520122262
Annuals > 0 > income Statement > total Other Income Expense Net
-2087000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
30453000
Annuals > 0 > balance Sheet > short Term Investments
8000
Annuals > 0 > balance Sheet > receivables
3713000
Annuals > 0 > balance Sheet > inventories
2269000
Annuals > 0 > balance Sheet > total Current Assets
39376000
Annuals > 0 > balance Sheet > property Plant Equipment
10701000
Annuals > 0 > balance Sheet > total Assets
70632000
Annuals > 0 > balance Sheet > payables
462000
Annuals > 0 > balance Sheet > short Term Debt
1257000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
22752000
Annuals > 0 > balance Sheet > equity
47880000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-41758000
Annuals > 0 > cash Flow > depreciation
-202000
Annuals > 0 > cash Flow > change In Working Capital
31834000
Annuals > 0 > cash Flow > cash From Operations
-9823000
Annuals > 0 > cash Flow > capital Expenditures
1861000
Annuals > 0 > cash Flow > cash From Investing
-2931440
Annuals > 0 > cash Flow > cash From Financing
-1746000
Annuals > 0 > cash Flow > net Change In Cash
-13601000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.5912532688979881
Annuals > 0 > ratios > PB
50.447320000000005
Annuals > 0 > ratios > ROE
-87.21386800334169
Annuals > 0 > ratios > ROA
-59.12051194925812
Annuals > 0 > ratios > FCF
-11684000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.5952114111054508
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
11579000
Annuals > 1 > income Statement > cost Of Revenue
7849000
Annuals > 1 > income Statement > gross Profit
3730000
Annuals > 1 > income Statement > operating Expenses
33246000
Annuals > 1 > income Statement > operating Income
-29516000
Annuals > 1 > income Statement > interest Expense
682000
Annuals > 1 > income Statement > pretax Income
-28568000
Annuals > 1 > income Statement > net Income
-28292000
Annuals > 1 > income Statement > eps
-0.40058761156333833
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
70626248
Annuals > 1 > income Statement > income Tax Expense
-768000
Annuals > 1 > income Statement > EBITDA
-18243000
Annuals > 1 > income Statement > operating Margin
-254.9097504102254
Annuals > 1 > income Statement > total Other Income Expense Net
948000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
44054000
Annuals > 1 > balance Sheet > short Term Investments
9000
Annuals > 1 > balance Sheet > receivables
27493000
Annuals > 1 > balance Sheet > inventories
3023780
Annuals > 1 > balance Sheet > total Current Assets
86448000
Annuals > 1 > balance Sheet > property Plant Equipment
15219000
Annuals > 1 > balance Sheet > total Assets
133815000
Annuals > 1 > balance Sheet > payables
2311000
Annuals > 1 > balance Sheet > short Term Debt
1209000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
46573000
Annuals > 1 > balance Sheet > equity
87242000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-28292000
Annuals > 1 > cash Flow > depreciation
9643000
Annuals > 1 > cash Flow > change In Working Capital
-6337350
Annuals > 1 > cash Flow > cash From Operations
-24991000
Annuals > 1 > cash Flow > capital Expenditures
671000
Annuals > 1 > cash Flow > cash From Investing
-13935000
Annuals > 1 > cash Flow > cash From Financing
-3967000
Annuals > 1 > cash Flow > net Change In Cash
-42919000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.40058761156333833
Annuals > 1 > ratios > PB
27.6864088581188
Annuals > 1 > ratios > ROE
-32.42933449485339
Annuals > 1 > ratios > ROA
-21.142622277024252
Annuals > 1 > ratios > FCF
-25662000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.2162535624838067
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
21040000
Annuals > 2 > income Statement > cost Of Revenue
15294000
Annuals > 2 > income Statement > gross Profit
5746000
Annuals > 2 > income Statement > operating Expenses
22348000
Annuals > 2 > income Statement > operating Income
-16602000
Annuals > 2 > income Statement > interest Expense
476068
Annuals > 2 > income Statement > pretax Income
-20053000
Annuals > 2 > income Statement > net Income
-22201000
Annuals > 2 > income Statement > eps
-0.31434488775334635
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
70626248
Annuals > 2 > income Statement > income Tax Expense
2148000
Annuals > 2 > income Statement > EBITDA
-11677000
Annuals > 2 > income Statement > operating Margin
-78.90684410646388
Annuals > 2 > income Statement > total Other Income Expense Net
3340000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
86973000
Annuals > 2 > balance Sheet > short Term Investments
9000
Annuals > 2 > balance Sheet > receivables
38003121
Annuals > 2 > balance Sheet > inventories
3027000
Annuals > 2 > balance Sheet > total Current Assets
127238000
Annuals > 2 > balance Sheet > property Plant Equipment
3272000
Annuals > 2 > balance Sheet > total Assets
140901000
Annuals > 2 > balance Sheet > payables
278000
Annuals > 2 > balance Sheet > short Term Debt
609000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
25685000
Annuals > 2 > balance Sheet > equity
115216000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-25730000
Annuals > 2 > cash Flow > depreciation
7918000
Annuals > 2 > cash Flow > change In Working Capital
-2565000
Annuals > 2 > cash Flow > cash From Operations
-13729000
Annuals > 2 > cash Flow > capital Expenditures
416000
Annuals > 2 > cash Flow > cash From Investing
-577000
Annuals > 2 > cash Flow > cash From Financing
-516000
Annuals > 2 > cash Flow > net Change In Cash
-14773000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.31434488775334635
Annuals > 2 > ratios > PB
20.96425567282322
Annuals > 2 > ratios > ROE
-19.26902513539786
Annuals > 2 > ratios > ROA
-15.756453112469037
Annuals > 2 > ratios > FCF
-14145000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.6722908745247148
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
95780000
Annuals > 3 > income Statement > cost Of Revenue
66102000
Annuals > 3 > income Statement > gross Profit
29678000
Annuals > 3 > income Statement > operating Expenses
31045000
Annuals > 3 > income Statement > operating Income
-1367000
Annuals > 3 > income Statement > interest Expense
239000
Annuals > 3 > income Statement > pretax Income
-9829000
Annuals > 3 > income Statement > net Income
-9728000
Annuals > 3 > income Statement > eps
-0.13773915895971142
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
70626248
Annuals > 3 > income Statement > income Tax Expense
-101000
Annuals > 3 > income Statement > EBITDA
-4196957
Annuals > 3 > income Statement > operating Margin
-1.4272290666109835
Annuals > 3 > income Statement > total Other Income Expense Net
-1932952
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
101746000
Annuals > 3 > balance Sheet > short Term Investments
9000
Annuals > 3 > balance Sheet > receivables
35870196
Annuals > 3 > balance Sheet > inventories
11461000
Annuals > 3 > balance Sheet > total Current Assets
158783000
Annuals > 3 > balance Sheet > property Plant Equipment
6382000
Annuals > 3 > balance Sheet > total Assets
183697000
Annuals > 3 > balance Sheet > payables
1363000
Annuals > 3 > balance Sheet > short Term Debt
424000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
41882000
Annuals > 3 > balance Sheet > equity
141815000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-9728000
Annuals > 3 > cash Flow > depreciation
7882000
Annuals > 3 > cash Flow > change In Working Capital
37185000
Annuals > 3 > cash Flow > cash From Operations
15689000
Annuals > 3 > cash Flow > capital Expenditures
4100000
Annuals > 3 > cash Flow > cash From Investing
-5027000
Annuals > 3 > cash Flow > cash From Financing
-599000
Annuals > 3 > cash Flow > net Change In Cash
9981000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.13773915895971142
Annuals > 3 > ratios > PB
17.03217347671262
Annuals > 3 > ratios > ROE
-6.859641081690936
Annuals > 3 > ratios > ROA
-5.295677120475566
Annuals > 3 > ratios > FCF
11589000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.12099603257465023
Annuals > 3 > health Score
38
Valuation > metrics > PE
-0.044898321655144416
Valuation > metrics > PB
51.490615978351165
Valuation > final Score
20
Valuation > verdict
1616.4% Overvalued
Profitability > metrics > ROE
-6.6631376481944
Profitability > metrics > ROA
-9.396257142755548
Profitability > metrics > Net Margin
-0.31783706415176793
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.46480861014387165
Risk > metrics > Interest Coverage
-20.34787512612676
Risk > final Score
-21
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.239718368781821
Liquidity > metrics > Quick Ratio
8.423505298929262
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
37
Prev Risks > 1
-28
Prev Risks > 2
-31
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:02:55.760Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.1
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.1
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-30
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-26
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.25
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.25
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-05-30
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-09-30
Earnings History > 4 > report Date
2023-11-29
Earnings History > 4 > date
2023-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-06-30
Earnings History > 5 > report Date
2023-09-28
Earnings History > 5 > date
2023-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-04-27
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-30
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-09-29
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-03-31
Earnings History > 9 > report Date
2022-06-01
Earnings History > 9 > date
2022-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-09-30
Earnings History > 10 > report Date
2021-12-01
Earnings History > 10 > date
2021-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-06-30
Earnings History > 11 > report Date
2021-09-27
Earnings History > 11 > date
2021-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-03-31
Earnings History > 12 > report Date
2021-04-09
Earnings History > 12 > date
2021-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2020-09-30
Earnings History > 13 > report Date
2020-12-02
Earnings History > 13 > date
2020-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2020-06-30
Earnings History > 14 > report Date
2020-09-17
Earnings History > 14 > date
2020-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2020-03-31
Earnings History > 15 > report Date
2020-05-14
Earnings History > 15 > date
2020-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-09-30
Earnings History > 16 > report Date
2019-11-27
Earnings History > 16 > date
2019-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2019-06-30
Earnings History > 17 > report Date
2019-09-26
Earnings History > 17 > date
2019-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2019-03-31
Earnings History > 18 > report Date
2019-04-30
Earnings History > 18 > date
2019-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2018-09-30
Earnings History > 19 > report Date
2018-11-28
Earnings History > 19 > date
2018-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2018-06-30
Earnings History > 20 > report Date
2018-09-26
Earnings History > 20 > date
2018-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2018-03-31
Earnings History > 21 > report Date
2018-05-30
Earnings History > 21 > date
2018-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2017-03-31
Earnings History > 22 > report Date
2017-05-31
Earnings History > 22 > date
2017-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa. The company was incorporated in 2006 and is based in Le Vésinet, France.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 3
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Novacyt
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.1
EPS Estimate
0
EPS Difference
-0.1
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.